Opportunity RFA-CA-10-012

The summary for the Opportunity RFA-CA-10-012 grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Opportunity RFA-CA-10-012: Purpose. This funding opportunity announcement solicits applications for the program known as Minority-Based Community Clinical Oncology Program (Minority-Based CCOP). This program allows practicing oncologists who serve large minority populations to participate in NCI-sponsored clinical trials. The purpose of this program is to support, as a national resource, research activities of physicians involved in the care of minorities who are eligible to participate in NCI-sponsored cancer prevention, control, and treatment clinical trials. The NCI clinical trials program supports CCOPs by providing access to clinical trials in cancer centers, major university centers, and community programs. The linkage of minority cancer patients/participants to the current clinical trials network facilitates the transfer of new research advancements in cancer prevention/control/treatment practices to minority communities and their physicians. The CCOP Network consists of three components each with its own FOA. The components are as follows: Minority Based-CCOPs (covered by this FOA), CCOP Groups (also referred to as CCOPs), and CCOP Research Bases. The Minority Based CCOPs are described in the previous paragraph. A Minority-Based CCOP encompasses community oncologists who accrue patients/participants to NCI-approved clinical trials. These trials are designed and conducted by the CCOP Research Bases, which also manage and analyze the data, and report the results. CCOP Research Bases must be located either at an NCI-supported Clinical Cooperative Group or at an NCI-designated Cancer Center. CCOP was established in 1983 to develop and conduct state-of-the-art cancer prevention, control and treatment clinical trials with significant involvement of community oncologists and populations they serve. The CCOP Network mission includes: (1) accelerating development of interventions to prevent and treat cancer and its symptoms by increasing accrual to trials; (2) fostering quality care in the community through adoption of results from clinical trials; and (3) increasing the involvement of minority and underserved patient/participant populations in cancer clinical trials and associated research. Mechanism of Support. This FOA will utilize the NIH U10 cooperative agreement award mechanism. Parallel FOAs (RFA-CA-10-010 and RFA-CA-10-011) solicit applications for Minority-Based CCOPs and CCOP Research Bases, respectively. It is imperative that Minority-Based CCOP applicants familiarize themselves with these parallel FOAs.
Federal Grant Title: Opportunity RFA-CA-10-012
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CA-10-012
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.393
CFDA Descriptions: Cancer Cause and Prevention Research
Current Application Deadline: Sep 16, 2010
Original Application Deadline: Sep 16, 2010
Posted Date: Jul 16, 2010
Creation Date: Jul 16, 2010
Archive Date: Oct 17, 2010
Total Program Funding: $2,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards: 5
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Cli...
Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New C...
Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer ...
Genomic Data Analysis Network: Genomic Data Center (U24 Clinical Trial Not Allowed)
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed...
Pilot Studies in Pancreatic Cancer
Cancer Prevention Research Small Grant Program
Molecular Targets for Nutrients in Prostate Cancer Prevention
More Grants from the National Institutes of Health
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource...
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24)...
New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Tria...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2021 FederalGrants.com